Oliger Christy J.

Oliger Christy J. is listed in filings as Director at Vera Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including 8 public disclosures. Recent filings connect the profile to Vera Therapeutics, Inc. (VERA), Replimune Group, Inc. (REPL), LAVA Therapeutics N.V. (LVTX), and Karyopharm Therapeutics Inc. (KPTI). The current snapshot covers public activity from Feb 18, 2025 to May 26, 2026. Reported amounts are shown as $296.7K to $338.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.